期刊文献+

来氟米特对家兔动脉粥样硬化形成的影响 被引量:3

Effects of Leflunomide on Experimental Atherogensis of Rabbits
下载PDF
导出
摘要 目的研究免疫抑制剂来氟米特对兔动脉粥样硬化形成的影响。方法24只新西兰大白兔随机分为三组:正常饮食组、高脂饮食组和高脂饮食+来氟米特治疗组。在0周和8周时测定血清中血脂、肿瘤坏死因子α、白介素介素6浓度。免疫组织化学染色测定斑块处巨噬细胞数量。图像分析观察主动脉斑块内膜面积比。结果来氟米特对血脂无明显影响,但可使肿瘤坏死因子α、白介素介素6、主动脉斑块内膜面积比及斑块处的巨噬细胞数较高脂饮食组显著降低(P均<0.001)。结论来氟米特可显著抑制动脉粥样硬化部位的炎症反应,对兔动脉粥样硬化有预防作用。 Aim To access the effects of leflunomide on experimental atherogensis of rabbits. Methods 24 New Zealand White rabbits were devided into three groups, 8 rabbits were selected as normal-diet control group, 8 rabbits as high-dlet control, the others as treatment group administered with leflunomide (5 mg/d)..Serum lipids, intedeuldn-6 (IL-6), tumor necrosis factor-alpha (TNF-α), atherosclerotic plaque/intima size ratio of aorta and the number of infiltrating macrophage in plaques were detected on the 0, 8 th week. Results Leflunomide had no effect on the lipids compared with control groups, the level of circulating TNF-α, IL-6, plaque/intima size ratio and the number of infiltrating macrophage in the treatment group was lower than that of control groups (all P 〈 0.001 ). Conclusions LEF oould inhibit the inflammation in the lesion of atheroselerosis of rabbits and attenuate atherogensis of rabbits.
出处 《中国动脉硬化杂志》 CAS CSCD 2005年第4期432-434,共3页 Chinese Journal of Arteriosclerosis
关键词 病理学与病理生理学 来氟米特对动脉粥样硬化形成的影响 免疫组织化学 来氟米特 动脉粥样硬化 肿瘤坏死因子Α 白介素介素6 Leflunomide Atheroselerosis Tumor Necrosis Factor-a Interleukin-6 Macrophage Inflammation
  • 相关文献

参考文献14

  • 1Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med, 1999, 340 (2): 115-126.
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105 (9): 1 135-143.
  • 3Jianglin Fan,Teruo Watanabe,王燕翻.炎症反应在动脉粥样硬化发病学中的作用[J].中国动脉硬化杂志,2003,11(7):706-708. 被引量:15
  • 4李后开,戴敏.内皮细胞炎症反应在动脉粥样硬化研究中的作用[J].中国动脉硬化杂志,2004,12(5):607-610. 被引量:20
  • 5Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol, 1997, 24 (3): 445-451.
  • 6Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore), 1989, 68 (3): 141-150.
  • 7Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med, 2003, 349 (25): 2 399-406.
  • 8Bartlett RR, Brendel S, Zielinski T, Schorlemmer HU. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Transplant Proc, 1996, 28 (6): 3 074-078.
  • 9Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol, 2001, 21 (12): 1 876-890.
  • 10Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res, 2002, 1 (4): 281-291.

二级参考文献40

  • 1Ross R. Atherosclerosis an inflammatory disease. N Engl J Med, 1999, 340 (2):115
  • 2Taylor Robinson D, Thomas BJ. Chlamydia pneumonia in arteries:the facts, the interpretation, and future studies. J Clin Pathol, 1998, 5 (11): 793-797
  • 3王金良.微生物感染与动脉粥样硬化[J].当代医学,2001,7(10):22-26.
  • 4Vink H, Constantinescu AA, Spaan Jos AE. Oxidized lipoproteins degrade the endothelial surface layer implications for platelet-endothelial cell adhesion. Circulation, 2000, 101 (13): 1 500-502
  • 5Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation, 2001, 103 (4): 491-495
  • 6Klouche M, Rose-John S, Schmiedt W, Bhakdi S. Enzymatically degrade, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation, 2000, 101 (15): 1 799-805
  • 7Anwar A, Zahid AA. Tumor necrosis factor-αregulates insulin-like growth factor blinding protein-3 expression in vascular smooth muscle. Circulation, 2002, 105 (10): 1 220
  • 8Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation, 2001, 104 (3): 365
  • 9Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, et al. Angiotensin Ⅱinduced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res, 1997, 81 (5): 804-811
  • 10Kranzhofer R, Schmidt J, Pferffer CAH, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999, 19 (7): 1 623-629

共引文献33

同被引文献44

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部